Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Circ Heart Fail. 2023 Sep 4;16(10):e010555. doi: 10.1161/CIRCHEARTFAILURE.123.010555

Table 3.

Longitudinal Cardiac MRI features of the RV functional recovery (RVFnRec) and no recovery (No RVFnRec) cohorts.

RVFnRec (n=22) No RVFnRec (n=41)
Baseline Follow-Up Mean Change Relative Change P-value* Baseline Follow-Up Mean Change Relative Change P-value* P-Value P-Value
RVEDVI
(mL/m2)
119.5
[104.0,145.7]
92.3
[75.5,102.7]
−34.5±24.6 −25.5±14.1 <0.001 105
[87.5,131.8]
114.0
[88.2,159.0]
8.7±26.5 9.0±26.8 0.04 <0.001 <0.001
RVESVI
(mL/m2)
92.3
[74.5,105.1]
35.5
[31.0,40.0]
−37.6±18.2 −39.6±13.3 <0.001 71.2
[57.4,101.9]
73.2
[57.5,123.8]
1.6±25.1 6.2±37.7 0.88 <0.001 <0.001
RVEF (%) 26.6±6.7 43.0±7.4 15.7±7.1 55.7±35.9 <0.001 27.7±10.3 32.0±8.7 4.4±11.0 32.4±62.8 0.02 <0.001 0.12
RVMI
(gm/m2)
44.6
[34.1,51.3]
35.4
[29.8,40.5]
−1.1±28.2 −2.1±41.0 0.12 50.0
[29.4,60.5]
43.9
[33.0,59.2]
−1.2±13.0 0.2±30.6 0.50 0.94 0.89
RV M/V
(gm/mL)
0.4
[0.3,0.52]
0.37
[0.33,0.45
0.1±0.1 22.0±33.7 0.45 0.42
[0.3,0.6]
0.34
[0.30,0.50]
−0.04±0.1 −7.2±22.8 0.61 0.06 0.07
RV SV/ESV 0.37±0.1 0.72±0.3 0.34±0.2 98.0±66.8 <0.001 0.41±0.2 0.5±0.2 0.1±0.2 51.4±93.9 0.04 <0.001 0.04
LVEDVI
(mL/m2)
47.5
[44.8,59.7]
66.3
[51.5,75.9]
10.7±16.9 28.6±44.3 0.006 49.0
[39.5,54.9]
63.8
[55.1,76.2]
16.8±15.4 35.4±32.4 <0.001 0.22 0.56
LVESVI
(mL/m2)
25.0
[17.1,26.9]
26.6
[17.7,36.4]
1.7±9.9 12.6±46.0 0.21 22.0
[15.3,27.8]
26.6
[23.2,32.8]
8.3±9.3 46.8±52.4 <0.001 0.02 <0.001
LVEF (%) 54.0
[46.2,61.3]
56.8
[54.8,68.3]
7.2±9.9 15.6±19.9 0.01 54.0
[46.9,67.3]
57.1
[53.3,60.8]
−1.3±11.5 −0.2±19.8 0.68 0.01 0.01
LVMI
(gm/m2)
36.8±6.1 42.4±26.3 22.0±5.1 62.3±13.2 0.28 45.0±16.9 42.3±18.7 −3.5±19.8 1.1±52.0 0.73 0.12 0.15
TR volume
(mL)
3.0
[0,14.0]
7.0
[0,21.8]
7.6±10.9 0.23 6.0
[0,16]
5.0
[0,16.0]
−0.8±16.4 1.0 0.4
TR fraction
(%)
0.0
[0,24.6]
9.8
[0,33.6]
10.1±18.5 0.04 5.0
[0,32]
8.2
[0,27.7]
−2.5±21.4 0.004 0.2

Values are mean ± SD, median [P25,P75], or N (%). RVEDVI, right ventricular end-diastolic volume index; RVESVI, right ventricular end-systolic volume index; RVEF, right ventricular ejection; RVMI, right ventricular mass index; RV M/V, right ventricular mass/volume; RV SV/ESV, right ventricular stroke volume/end-systolic volume; LVEDVI, left ventricular end-diastolic volume index; LVESVI, left ventricular end-systolic volume index; LVEF, left ventricular ejection-fraction; LVMI, left ventricular mass index; TR volume, tricuspid regurgitant volume; TR fraction, tricuspid regurgitant volume fraction (relative to stroke volume) fraction. P values calculated as follows: Wilcoxon signed-rank non-parametric test for related samples (within cohort) or repeated measures ANOVA (between cohort).

*

P-value for within cohort change from baseline to follow-up;

p value for between cohort change baseline to follow-up;

p-value for between group relative change (as % baseline value) baseline to follow-up.